文献速递血栓与止血造血干细胞移植与细胞治疗

单细胞分析识别内皮静脉血栓栓塞特征可预测免疫治疗耐药与生存

Single-cell analysis identifies endothelial venous thromboembolism signatures as predictors of immunotherapy resistance and survival across cancers.
PubMed 文献 · J Thromb Haemost · 2026-05-19

本研究系统分析38个单细胞RNA测序数据集,发现内皮细胞是肿瘤微环境中VTE相关转录特征的主要载体,高VTE评分内皮细胞富集凝血与免疫抑制程序。基于TCGA和GEO数据构建含12个核心基因的内皮来源VTE分子模型Endo.VTM,在多癌种中具预后价值并与免疫检查点表达、免疫功能障碍及免疫治疗反应相关。

要点

  • 内皮细胞是肿瘤微环境中VTE相关转录特征的主要载体。
  • 高VTE评分内皮细胞富集凝血、免疫抑制和细胞通讯改变。
  • Endo.VTM含12个核心基因,与免疫治疗反应相关。

核心结论

  • 内皮细胞是肿瘤微环境中血栓相关转录的核心调控者,揭示VTE、免疫逃逸与肿瘤进展的新轴。
  • Endo.VTM为预后分层提供临床可操作的框架。

研究设计与样本

  • 系统分析38个单细胞RNA测序数据集,覆盖多种肿瘤类型。
  • 基于TCGA和GEO的bulk RNA-seq数据构建Endo.VTM模型。
  • 进行CRISPR-Cas9依赖筛选。

主要发现

  • 高VTE评分内皮细胞转录程序富集凝血、免疫抑制和细胞间信号改变。
  • Endo.VTM含12个核心基因,在多种癌症中显示稳健预后价值。
  • Endo.VTM与免疫检查点表达、肿瘤免疫功能障碍及免疫治疗反应显著相关。
  • CRISPR-Cas9依赖筛选揭示模型基因中的治疗脆弱性。

临床怎么用

  • Endo.VTM可用于跨癌种预后分层。
  • VTE相关内皮特征可提示免疫治疗耐药风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous thromboembolism (VTE) is a major complication in cancer patients, yet the transcriptional mechanisms by which tumor-associated endothelial cells drive thrombogenesis and immune evasion remain poorly understood. OBJECTIVES: This study characterized VTE-related transcriptional signatures in the tumor microenvironment (TME), identified endothelial-specific risk genes, and developed a prognostic model linking hypercoagulation, immune dysfunction, and tumor progression. METHODS: We systematically analyzed 38 single-cell RNA-sequencing (scRNA-seq) datasets from diverse tumor types to characterize VTE-related gene expression across the TME. Endothelial cells were identified as the primary carriers of the transcriptional signatures of VTE. A VTE score was computed at the single-cell level to describe high-risk endothelial cell subsets. Functional annotation, intercellular communication analysis, and immune profiling were performed to assess the phenotypic and immunologic roles of these genes. Based on bulk RNA-seq datasets from The Cancer Genome Atlas and Gene Expression Omnibus, an endothelial-derived VTE molecular model (Endo.VTM) was constructed. Clustered regularly interspaced short palindromic repeats-associated protein 9 dependency screening was also performed. RESULTS: Endothelial cells with high-VTE scores showed transcriptional programs enriched for coagulation, immune suppression, and altered cell-cell signaling. The Endo.VTM, comprising 12 core genes, demonstrated robust prognostic value across multiple cancer types and was significantly associated with immune checkpoint expression, tumor immune dysfunction, and response to immunotherapy. Clustered regularly interspaced short palindromic repeats-associated protein 9 dependency screening highlights therapeutic vulnerabilities among model genes. CONCLUSION: We revealed that endothelial cells serve as central regulators of thrombosis-related transcription in the TME and revealed a novel axis linking VTE, immune evasion, and tumor progression. The Endo.VTM offers a clinically actionable framework for prognostic stratification.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Guan H, Lv P, Li X, et al. Single-cell analysis identifies endothelial venous thromboembolism signatures as predictors of immunotherapy resistance and survival across cancers. J Thromb Haemost. 2026. PMID: 42162740. doi:10.1016/j.jtha.2026.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。